Total Funding
37
46
Total FundingVenture - Series Unknown raised
Growth Score
-19 pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
141557
SkinJect develops a novel drug delivery system for the treatment of non-melanoma skin cancers.
- Louis Falo: Co-Founder
- James Nolan: CEO
Medicus Pharma
About the Company
SkinJect develops a novel drug delivery system for the treatment of non-melanoma skin cancers. Its system comprises a dissolvable microneedle array (MNA) to deliver a drug directly into the top layer of the skin. The drug will kill non-melanoma skin cancer by causing an immune system reaction to combat the disease.
It was founded in 2015 and is
headquartered in Pittsburgh, Pennsylvania.
